Abiraterone Acetate Tablets USP 250/500 mg

Abiraterone Acetate Tablets USP 250/500 mg
Product Description

A White to off-white coloured elongated shaped biconvex uncoated tablet having break line on one side and plain on another side. Abiraterone Acetate treats prostate cancer that has spread to other parts of the body.

Read more Show less

BIOZENTA ONCOLOGY

  • IN
  • 2023
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

BIOZENTA ONCOLOGY

  • IN
  • 2023
    On CPHI since
  • 4
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
View company profile

More Products from BIOZENTA ONCOLOGY (4)

  • Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    Product Goserlin Acetate Injection 3.6 mg/10.8 mg/vial

    A White or almost white Lyophilized powder filled in 5 ml clear tubular glass vial. Goserlin Injection is used for the treatment of prostate cancer in men and for breast cancer, endometriosis and uterine fibroids in women. In combination with some other medicine, it is used in the treatment of female infe...
  • Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    Product Idarubicin Hydrochloride Injection 5/10/20 mg/vial ( As Lyophilized)

    A reddish orange colored lyophilized cake filled in 5 ml amber glass vial. Idarubicin is an anthracycline antineoplastic agent used to treat acute myeloid leukemia (AML) in adults.
  • Treosulfan For Injection 1/5 mg/vial

    Product Treosulfan For Injection 1/5 mg/vial

    Vials containing 1 g or 5 g treosulfan. Powder for solution for injection/infusion. A white crystalline odourless powder. Treosulfan is indicated for the palliative treatment of epithelial ovarian cancer.
  • Triptoreline Injection 3.75/11.25/22.5 mg/vial

    Product Triptoreline Injection 3.75/11.25/22.5 mg/vial

    White to off white color lyophilized powder filled in clear tubular glass vial. Triptorelin is a GnRH agonist indicated for the palliative treatment of advanced prostate cancer. Triptorelin is a synthetic decapeptide agonist analog of luteinizing hormone releasing hormone (LHRH). Possessing greater potency...

BIOZENTA ONCOLOGY resources (1)

  • Company Brochure

    Brochure Company Brochure

    We are manufacturer and exporter of Oncology/Anticancer, General Range and Critical Care Finish Formulations. The formulation facility is WHO GMP certified and has an ultramodern, well equipped, dedicated setup for manufacturing of Liquid Injectables, Lyophilized Injectables, Prefilled Syringes, Tablets and Capsules.